STAT+: Pharmalittle: FDA panel to review over-the-counter birth control pill; Alzheimer’s drugs may lead to haves and have-nots
An FDA advisory panel will meet this week to review an application by Perrigo to sell a decades-old birth control pill over the counter.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and inspiring, because that oh-so familiar
